Evidence map›Paper›PMID 28593245›Full record

ArticleInvestigative ophthalmology & visual science2017

A GPR119 Signaling System in the Murine Eye Regulates Intraocular Pressure in a Sex-Dependent Manner.

Sally Miller, Sherry Shu-Jung Hu, Emma Leishman, Dan Morgan, Jim Wager-Miller, Ken Mackie, Heather B Bradshaw, Alex Straiker

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Therapeutic Potential of Cannabinoids in Glaucoma.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  4. Article
  5. Endocannabinoid signaling pathways: beyond CB1R and CB2R.Journal of cell communication and signaling · 2021
    Review
  6. Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma.International journal of molecular sciences · 2021
    Review
  7. Article
  8. THC Regulates Tearing via Cannabinoid CB1 Receptors.Investigative ophthalmology & visual science · 2020
    Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Sally MillerDepartment of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana, United States.
Sherry Shu-Jung HuDepartment of Psychology, National Cheng Kung University, Tainan, Taiwan.
Emma LeishmanDepartment of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana, United States.
Dan MorganDepartment of Anesthesiology, Penn State University College of Medicine, Hershey, Pennsylvania, United States.
Jim Wager-MillerDepartment of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana, United States.
Ken MackieDepartment of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana, United States.
Heather B BradshawDepartment of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana, United States.
Alex StraikerDepartment of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana, United States.
Indiana University Bloomington · USNational Cheng Kung University · TWPenn State Milton S. Hershey Medical Center · US

Funding

Neuronal cannabinoidsR01DA011322 · NIDA · UNIVERSITY OF WASHINGTON · PI MACKIE, KENNETH · 1998 to 2014
$3.4M
Cannabinoid Modulation of Cell FunctionK05DA021696 · NIDA · TRUSTEES OF INDIANA UNIVERSITY · PI MACKIE, KENNETH · 2007 to 2017
$1.3M
Harnessing endogenous cannabinoids for ocular healthR01EY024625 · NEI · TRUSTEES OF INDIANA UNIVERSITY · PI STRAIKER, ALEXANDER J · 2014 to 2017
$1.3M
GPR119: A novel means to lower intraocular pressure?R21EY021831 · NEI · TRUSTEES OF INDIANA UNIVERSITY · PI STRAIKER, ALEXANDER J · 2011 to 2012
$424k
NEI NIH HHS R01 EY024625NEI NIH HHS R21 EY021831NIDA NIH HHS K05 DA021696NIDA NIH HHS R01 DA011322
6 · The paper itself

Abstract

Purpose: GPR119 is a G protein-coupled receptor that may be the endogenous target for 2-oleoylglycerol (2-OG), a lipid related to the endocannabinoid family of neuromodulators. Interest in GPR119 has centered on its role in regulating insulin secretion; however, the role of GPR119 has not been examined in the eye. The purpose of this study was to explore a potential GPR119-based signaling system in the murine eye. Methods: We used a combination of RT-PCR, immunohistochemistry, lipid measurement, and IOP measurement in a normotensive mouse model, with GPR119 knockout mice as controls. Results: We detected GPR119 mRNA and protein in the anterior eye of the mouse and cow, with GPR119 mRNA levels elevated in female relative to male mice. GPR119 protein expression is most prominent in structures near the angle, including trabecular meshwork, as well as iris and corneal epithelium. We detected 2-OG in the anterior eye and detected alterations in lipid levels in GPR119 knockout versus wild type and also by sex. Last, we found that 2-OG preferentially reduces IOP in female mice in a normotensive model. Conclusions: In summary, we offer evidence for a GPR119-based signaling system in the mammalian eye, with receptors, ligands, and function in the form of a reduction in IOP. Notably this reduction in pressure is restricted to female mice.

Indexed as

Gene Expression RegulationAnimalsDisease Models, AnimalFemaleGlaucomaImmunohistochemistryIntraocular PressureMaleMiceMice, KnockoutReal-Time Polymerase Chain ReactionReceptors, G-Protein-CoupledRNA, MessengerSex FactorsSignal TransductionGpr119 protein, mouseReceptors, G-Protein-CoupledRNA, Messenger

Identifiers

PMID28593245
PMCPMC5469424
OpenAlexW2623918826

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.